All articles tagged: Attention-deficit hyperactivity disorder, predominantly hyperactive type (F90.1)
HealthDay
25 June at 03.04 PM
ADHD Meds May Help Control Opioid Use Disorder in PregnancyPsychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef |
HealthDay
30 January at 11.19 PM
Mislabeled Bottles Trigger Recall of the ADHD Drug ZenzediOne lot of Zenzedi (dextroamphetamine sulfate) 30-mg tablets is being recalled after a pharmacist found antihistamine tablets (carbinoxamine) in a bottle labeled as Zenzedi, according to a recall notice issued by Azurity Pharmaceuticals Inc.The recall comes amid an <a href="https://www.healthday.com/healthpro-news/child-health/amid-shortages-fe |
HealthDay
22 January at 04.50 PM
Sleep Disorders Differ for Autism, ADHD Versus Typical DevelopmentFor most types of sleep disorders, there are significant differences for children with autism spectrum disorder (ASD) and those with attention-deficit/hyperactivity disorder (ADHD) compared with typically developing (TD) children, according to a study published online Dec. 29 in Autism Research.Carmen Berenguer, Ph.D., from the Universi |
HealthDay
17 January at 11.52 PM
New Rx for Schedule-II Stimulants for ADHD Increased During PandemicIncident use of common behavioral health medications remained relatively stable during the COVID-19 pandemic, with the exception of those for attention-deficit/hyperactivity disorder (ADHD), according to a study published online Jan. 10 in JAMA Psychiatry.Grace Chai, Pharm.D., M.P.H., from the U.S. Food and Drug Administration i |
HealthDay
30 November at 09.59 PM
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHDThe presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in JAMA Network Open.Soo Min Jeon, Pharm.D., Ph.D., from Jeju National University in South Korea, and |
HealthDay
29 November at 10.47 PM
Before ADHD Diagnosis, Youth Twice as Likely to Have Used Health Care ServicesTwo years before attention-deficit/hyperactivity disorder (ADHD) diagnosis, youth with ADHD are twice as likely to use health care services as youth without the condition, according to a study published online Oct. 30 in the Archives of Disease in Childhood.Vibhore Prasad, Ph.D., from King's College London, and colleagues used p |
HealthDay
27 November at 05.03 PM
Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVDLong-term exposure to attention-deficit/hyperactivity disorder (ADHD) medications is associated with an increased risk for cardiovascular disease (CVD), especially hypertension, according to a study published online Nov. 22 in JAMA Psychiatry.Le Zhang, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the assoc |
MedScape
28 November at 01.50 AM
Sleep-Disordered Breathing Common After StrokeSleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. |
Medpage Today
24 November at 08.00 PM
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-UpHOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... |
Medical xPress
23 November at 01.50 PM
RNA editing is the next frontier in gene therapy—here's what you need to knowThe United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. |
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |